( March 6, 2025, 12:54 PM EST) -- WASHINGTON, D.C. — For the third time this year, the Federal Circuit U.S. Court of Appeals on March 5 affirmed a West Virginia federal judge’s decision to grant a preliminary injunction against a biosimilar manufacturer that barred it from marketing products that were biosimilars to an eye medication patented by Regeneron Pharmaceuticals Inc....